相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis
J. S. Bajaj et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed
Sudhir Maharshi et al.
GUT (2015)
Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy
N. Kimer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization
Kavish R. Patidar et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy
Kevin D. Mullen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup et al.
HEPATOLOGY (2014)
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Jasmohan S. Bajaj et al.
JOURNAL OF HEPATOLOGY (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: Implications for the gut-liver-brain axis
Vishwadeep Ahluwalia et al.
METABOLIC BRAIN DISEASE (2014)
Risk factors and outcome of bacterial infections in cirrhosis
Tony Bruns et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
Barjesh Chander Sharma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids
Lotta K. Stenman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study
Dorota Koziarska et al.
BMC GASTROENTEROLOGY (2013)
Evolving Concepts: The Negative Effect of Minimal Hepatic Encephalopathy and Role for Prophylaxis in Patients With Cirrhosis
Ravi K. Prakash et al.
CLINICAL THERAPEUTICS (2013)
Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
Jiannis Vlachogiannakos et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Genta Kakiyama et al.
JOURNAL OF HEPATOLOGY (2013)
Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications
Pablo Bellot et al.
LIVER INTERNATIONAL (2013)
Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
Jasmohan S. Bajaj et al.
PLOS ONE (2013)
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites
Georgios N. Kalambokis et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009
Maria Stepanova et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Serum fatty-acid composition and the risk of Alzheimer's disease: a longitudinal population-based study
E. Ronnemaa et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2012)
The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
Mohamad A. Hanouneh et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
RATES OF COMMONLY OCCURING INFECTIONS IN CIRRHOSIS PATIENTS REMAIN STABLE DURING LONG-TERM RIFAXIMIN TREATMENT
A. Sanyal et al.
JOURNAL OF HEPATOLOGY (2012)
Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota
Matteo Garcovich et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement
J. S. Bajaj et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Minimal Hepatic Encephalopathy Is Associated With Falls
Eva Roman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
K. B. M. Saiful Islam et al.
GASTROENTEROLOGY (2011)
Pharmacotherapy for Hepatic Encephalopathy
Paula V. Phongsamran et al.
DRUGS (2010)
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
Vasiliki Arvaniti et al.
GASTROENTEROLOGY (2010)
Clinical Course of Alcoholic Liver Cirrhosis: A Danish Population-Based Cohort Study
Peter Jepsen et al.
HEPATOLOGY (2010)
Gut Flora and Hepatic Encephalopathy in Patients with Cirrhosis
Stephen M. Riordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pharmacoeconomics of Hepatic Encephalopathy
Guy Neff
PHARMACOTHERAPY (2010)
Rifaximin for Treatment of Hepatic Encephalopathy
Darego O. Maclayton et al.
ANNALS OF PHARMACOTHERAPY (2009)
Spectrum of Neurocognitive Impairment in Cirrhosis: Implications for the Assessment of Hepatic Encephalopathy
Jasmohan S. Bajaj et al.
HEPATOLOGY (2009)
Minimal Hepatic Encephalopathy Is Associated with Motor Vehicle Crashes: The Reality Beyond the Driving Test
Jasmohan S. Bajaj et al.
HEPATOLOGY (2009)
Rifaximin for the treatment of hepatic encephalopathy
Rachel Tavares De Melo et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis
Qian Jiang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Rifaximin for the treatment of hepatic encephalopathy
Kenneth R. Lawrence et al.
PHARMACOTHERAPY (2008)
Bacterial infections, sepsis, and multiorgan failure in cirrhosis
Puneeta Tandon et al.
SEMINARS IN LIVER DISEASE (2008)
An algorithm for the management of hepatic encephalopathy
Kevin D. Mullen et al.
SEMINARS IN LIVER DISEASE (2007)
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
Srinivasa Prasad et al.
HEPATOLOGY (2007)
Deoxycholic acid induces intracellular signaling through membrane perturbations
Samira Jean-Louis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Bile salt biotransformations by human intestinal bacteria
JM Ridlon et al.
JOURNAL OF LIPID RESEARCH (2006)
The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation
D Shawcross et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: A prospective randomized study
YH Paik et al.
YONSEI MEDICAL JOURNAL (2005)
Rifaximin, a poorly absorbed antibiotic: Pharmacology and clinical potential
C Scarpignato et al.
CHEMOTHERAPY (2005)
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, doubledummy, controlled clinical trial
A Mas et al.
JOURNAL OF HEPATOLOGY (2003)
分享论文
